...
首页> 外文期刊>Macromolecular Research >Influence of Glyceryl Palmitostearate on Release Behaviors of Hydroxypropyl Cellulose Microcapsules Containing Indomethacin by W/O Emulsion
【24h】

Influence of Glyceryl Palmitostearate on Release Behaviors of Hydroxypropyl Cellulose Microcapsules Containing Indomethacin by W/O Emulsion

机译:棕榈硬脂酸甘油酯对W / O乳液对吲哚美辛羟丙基纤维素微胶囊释放行为的影响

获取原文
获取原文并翻译 | 示例

摘要

Hydrophilic hydroxypropyl cellulose (HPC) microcapsules containing the indomethacin model drug Were prepared using the water in oil (W/O) emulsion method. The effect of hydrophobic glyceryl palmitostearate (Precirol ATO 5) on the release behavior as well as the drug loading and encapsulation efficiency of the indometha-cin-loaded microcapsules was investigated as a function of the Precirol ATO 5 content. The microcapsules formed showed stable and spherical forms, whose particle sizes ranged from about 20 to 152 μm. X-ray diffraction analyses indicate that the indomethacin in the microcapsules was distributed in the form of molecular or very small crystals. The drug loading and encapsulation efficiency of the microcapsules slightly increased with increasing surfactant and Precirol ATO 5 content. In the dissolution test, pure HPC microcapsules showed rapid drug release, whereas HPC microcapsules containing Precirol ATO 5 showed a slower release rate. This behavior might be attributable to the hydrophobic Precirol ATO 5 coating on indomethacin, leading to the delayed effect on drug release in the medium.
机译:使用油包水(W / O)乳液法制备了含有消炎痛模型药物的亲水性羟丙基纤维素(HPC)微胶囊。研究了疏水性甘油硬脂酸甘油基硬脂酸酯(Precirol ATO 5)对释放行为以及载有吲哚美辛的微胶囊的载药量和包封效率的影响,并以此作为Precirol ATO 5含量的函数。形成的微囊显示出稳定的球形形式,其粒径范围为约20至152μm。 X射线衍射分析表明消炎痛在微胶囊中以分子或非常小的晶体的形式分布。随着表面活性剂和Precirol ATO 5含量的增加,微囊的载药量和包封效率略有提高。在溶出度测试中,纯的HPC微胶囊显示出快速的药物释放,而含有Precirol ATO 5的HPC微胶囊显示出较慢的释放速度。此行为可能归因于消炎痛上的疏水性Precirol ATO 5涂层,导致对介质中药物释放的延迟作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号